{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:48:38Z","timestamp":1789084118626,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012094","name":"F\u00e9d\u00e9ration Enfants Cancers Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.tranon.2026.102746","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:04:57Z","timestamp":1775304297000},"page":"102746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["CCL2: A double-edged sword in neuroblastoma, with a critical role in MYCN-amplified tumors"],"prefix":"10.1016","volume":"67","author":[{"given":"L\u00e9o","family":"Jannot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexia","family":"Gazeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-3585","authenticated-orcid":false,"given":"Nathalie","family":"Bendriss-Vermare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Pochon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-0125","authenticated-orcid":false,"given":"Herv\u00e9","family":"Sartelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.tranon.2026.102746_bib0001","first-page":"4","article-title":"Neuroblastome","volume":"42","author":"Plantaz","year":"2022","journal-title":"EMC - P\u00e9diatrie \u2013 Mal Infect."},{"issue":"7575","key":"10.1016\/j.tranon.2026.102746_bib0002","doi-asserted-by":"crossref","first-page":"700\u20114","DOI":"10.1038\/nature14980","article-title":"Telomerase activation by genomic rearrangements in high-risk neuroblastoma","volume":"526","author":"Peifer","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.tranon.2026.102746_bib0003","doi-asserted-by":"crossref","first-page":"211\u201121","DOI":"10.1007\/s00441-018-2796-z","article-title":"Origin and initiation mechanisms of neuroblastoma","volume":"372","author":"Tsubota","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.tranon.2026.102746_bib0004","doi-asserted-by":"crossref","first-page":"659\u2011702","DOI":"10.1146\/annurev-immunol-032713-120145","article-title":"Chemokines and chemokine receptors: positioning cells for host defense and immunity","volume":"32","author":"Griffith","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.tranon.2026.102746_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/170381","article-title":"Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment","volume":"2014","author":"Mukaida","year":"2014","journal-title":"Mediators. Inflamm."},{"issue":"2","key":"10.1016\/j.tranon.2026.102746_bib0006","doi-asserted-by":"crossref","first-page":"97\u2011102","DOI":"10.1016\/j.semcancer.2008.10.003","article-title":"Chemokines in neuroectodermal tumour progression and metastasis","volume":"19","author":"Raffaghello","year":"2009","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102746_bib0007","doi-asserted-by":"crossref","first-page":"859\u201174","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity."},{"issue":"16","key":"10.1016\/j.tranon.2026.102746_bib0008","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.3390\/ijms22168530","article-title":"Roles of CCL2-CCR2 axis in the tumor microenvironment","volume":"22","author":"Kadomoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.tranon.2026.102746_bib0009","doi-asserted-by":"crossref","first-page":"7351\u201170","DOI":"10.7150\/thno.74753","article-title":"Cancer-associated fibroblasts facilitate premetastatic niche formation through lncRNA SNHG5-mediated angiogenesis and vascular permeability in breast cancer","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics."},{"issue":"10","key":"10.1016\/j.tranon.2026.102746_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.tranon.2026.102746_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2019.08.006","article-title":"Blockade of CCL2\/CCR2 signaling pathway prevents inflammatory monocyte recruitment and attenuates OVA-induced allergic asthma in mice","volume":"214","author":"Jiang","year":"2019","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.tranon.2026.102746_bib0012","doi-asserted-by":"crossref","first-page":"376\u201187","DOI":"10.1158\/2326-6066.CIR-18-0633","article-title":"CCR2-Dependent recruitment of tregs and monocytes following radiotherapy is associated with tnf\u03b1-mediated resistance","volume":"7","author":"Mondini","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"6","key":"10.1016\/j.tranon.2026.102746_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152293","article-title":"The role of dendritic cells in neuroblastoma: implications for immunotherapy","volume":"227","author":"Zafari","year":"2022","journal-title":"Immunobiology"},{"issue":"10","key":"10.1016\/j.tranon.2026.102746_bib0014","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.3390\/cancers16101863","article-title":"The neuroblastoma microenvironment, heterogeneity and immunotherapeutic approaches","volume":"16","author":"Polychronopoulos","year":"2024","journal-title":"Cancers. (Basel)"},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19781-y","article-title":"Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma","volume":"11","author":"Melaiu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102746_bib0016","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fimmu.2020.00873","article-title":"Enhancing neuroblastoma immunotherapies by engaging iNKT and NK cells","volume":"11","author":"McNerney","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102746_bib0017","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002417","article-title":"Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma","volume":"9","author":"Bao","year":"2021","journal-title":"J. ImmunOther Cancer"},{"issue":"6","key":"10.1016\/j.tranon.2026.102746_bib0018","first-page":"1624\u201138","article-title":"Single-cell landscape analysis reveals distinct regression trajectories and novel prognostic biomarkers in primary neuroblastoma","volume":"9","author":"Liu","year":"2022","journal-title":"Genes. Dis."},{"issue":"9","key":"10.1016\/j.tranon.2026.102746_bib0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1084\/jem.20031462","article-title":"Natural killer T cells infiltrate neuroblastomas expressing the Chemokine CCL2","volume":"199","author":"Metelitsa","year":"2004","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.tranon.2026.102746_bib0020","doi-asserted-by":"crossref","first-page":"2702\u201112","DOI":"10.1172\/JCI30751","article-title":"Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma","volume":"117","author":"Song","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0021","first-page":"90\u2011102","article-title":"Regulation and function of CCL2 and N-myc in retinoic acid-treated neuroblastoma cells","volume":"22","author":"Murra","year":"2025","journal-title":"Cancer Genom. Proteom."},{"issue":"7","key":"10.1016\/j.tranon.2026.102746_bib0022","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1158\/2767-9764.CRC-21-0134","article-title":"Impaired antitumor immune response in MYCN -amplified neuroblastoma is associated with lack of CCL2 secretion and poor dendritic cell recruitment","volume":"2","author":"Kacher","year":"2022","journal-title":"Cancer Res. Commun."},{"key":"10.1016\/j.tranon.2026.102746_bib0023","article-title":"HIGH expression of ccl2 correlated with dendritic cell recruitment in neuroblastomas associated with opsoclonus-myoclonus syndrome","author":"Voirin","year":"2025","journal-title":"Lab Investig. J. Tech. Methods Pathol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102746_bib0024","doi-asserted-by":"crossref","first-page":"1730\u20118","DOI":"10.1021\/jf504934m","article-title":"6-shogaol, an active constituent of dietary ginger, impairs cancer development and lung metastasis by inhibiting the secretion of CC-chemokine ligand 2 (CCL2) in tumor-associated dendritic cells","volume":"63","author":"Hsu","year":"2015","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.tranon.2026.102746_bib0025","first-page":"5571\u201181","article-title":"CCR2 Plays a critical role in dendritic cell maturation: possible role of CCL2 and NF-\u03bab","volume":"184","author":"Jimenez","year":"2010","journal-title":"J. Immunol. Baltim Md 1950"},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0026","doi-asserted-by":"crossref","first-page":"5992","DOI":"10.1038\/s41467-020-19781-y","article-title":"Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma","volume":"11","author":"Melaiu","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.tranon.2026.102746_bib0027","first-page":"3332\u201141","article-title":"Tumor-derived chemokine MCP-1\/CCL2 is sufficient for mediating tumor tropism of adoptively transferred T cells","volume":"179","author":"Brown","year":"2007","journal-title":"J. Immunol. Baltim Md 1950"},{"issue":"6","key":"10.1016\/j.tranon.2026.102746_bib0028","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1320626","article-title":"Amplification of N-Myc is associated with a T-cell-poor microenvironment in metastatic neuroblastoma restraining interferon pathway activity and chemokine expression","volume":"6","author":"Layer","year":"2017","journal-title":"Oncoimmunology."},{"issue":"7355","key":"10.1016\/j.tranon.2026.102746_bib0029","doi-asserted-by":"crossref","first-page":"222\u20115","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.tranon.2026.102746_bib0030","doi-asserted-by":"crossref","first-page":"1286\u201191","DOI":"10.1016\/j.jpedsurg.2014.04.001","article-title":"Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma","volume":"49","author":"Li","year":"2014","journal-title":"J. Pediatr. Surg."},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0031","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40164-024-00550-2","article-title":"M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis","volume":"13","author":"Chen","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.102746_bib0032","doi-asserted-by":"crossref","first-page":"729\u201140","DOI":"10.1038\/s41593-019-0370-y","article-title":"Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39","volume":"22","author":"Takenaka","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"8","key":"10.1016\/j.tranon.2026.102746_bib0033","doi-asserted-by":"crossref","first-page":"3455\u201164","DOI":"10.1182\/blood-2007-12-129080","article-title":"Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx","volume":"112","author":"Dean","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tranon.2026.102746_bib0034","article-title":"Tertiary lymphoid structures-driven immune infiltration patterns and their association with survival in neuroblastoma","volume":"13","author":"Liu","year":"2025","journal-title":"PeerJ."},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0035","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2020.1836768","article-title":"Reduction of CD11b+ myeloid suppressive cells augments anti-neuroblastoma immune response induced by the anti-GD2 antibody ch14.18\/CHO","volume":"9","author":"Siebert","year":"2020","journal-title":"Oncoimmunology."},{"issue":"14","key":"10.1016\/j.tranon.2026.102746_bib0036","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.3390\/cancers15143535","article-title":"The promise of retinoids in the treatment of cancer: neither burnt out nor fading away","volume":"15","author":"Nagai","year":"2023","journal-title":"Cancers. (Basel)"},{"issue":"8","key":"10.1016\/j.tranon.2026.102746_bib0037","first-page":"780\u20118","article-title":"Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b","volume":"33","author":"Craddock","year":"2010","journal-title":"J. Immunother. Hagerstown Md 1997"},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0038","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-020-01165-x","article-title":"CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis","volume":"19","author":"Yang","year":"2020","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.tranon.2026.102746_bib0039","doi-asserted-by":"crossref","first-page":"93\u2011104","DOI":"10.1111\/imm.12023","article-title":"Anti-tumour strategies aiming to target tumour-associated macrophages","volume":"138","author":"Tang","year":"2013","journal-title":"Immunology"},{"issue":"7","key":"10.1016\/j.tranon.2026.102746_bib0040","doi-asserted-by":"crossref","first-page":"399\u2011416","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumor-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.tranon.2026.102746_bib0041","doi-asserted-by":"crossref","first-page":"1610\u201129","DOI":"10.1111\/bph.17429","article-title":"Carbonic anhydrase IX inhibition as a path to treat neuroblastoma","volume":"182","author":"Petrosiute","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.tranon.2026.102746_bib0042","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46968-2","article-title":"Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastoma","volume":"13","author":"Lascano","year":"2023","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.tranon.2026.102746_bib0043","doi-asserted-by":"crossref","first-page":"1020\u20117","DOI":"10.1002\/jcph.140","article-title":"Utilizing pharmacokinetics\/pharmacodynamics modeling to simultaneously examine free CCL2, total CCL2 and carlumab (CNTO 888) concentration time data","volume":"53","author":"Fetterly","year":"2013","journal-title":"J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.tranon.2026.102746_bib0044","doi-asserted-by":"crossref","first-page":"1740\u201150","DOI":"10.1183\/13993003.01558-2014","article-title":"CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab","volume":"46","author":"Raghu","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.tranon.2026.102746_bib0045","doi-asserted-by":"crossref","first-page":"2387\u201192","DOI":"10.1002\/art.21975","article-title":"A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis","volume":"54","author":"Haringman","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"5_suppl","key":"10.1016\/j.tranon.2026.102746_bib0046","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.5_suppl.92","article-title":"Overall survival in a trial of orally administered CCR2 inhibitor CCX872 in locally advanced\/metastatic pancreatic cancer: correlation with blood monocyte counts","volume":"36","author":"Linehan","year":"2018","journal-title":"J. Clin. Oncol."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326000835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:11:11Z","timestamp":1776510671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326000835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S1936523326000835"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102746","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CCL2: A double-edged sword in neuroblastoma, with a critical role in MYCN-amplified tumors","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102746"}}